|
|
|
Volumn 62 Suppl 2, Issue , 2004, Pages 387-391
|
|
New guideline for the treatment of osteoporosis
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALENDRONIC ACID;
CALCITONIN;
CALCIUM;
DRUG DERIVATIVE;
ETIDRONIC ACID;
FARNOQUINONE;
RISEDRONIC ACID;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
VITAMIN D;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
ESTROGEN THERAPY;
EVIDENCE BASED MEDICINE;
HUMAN;
META ANALYSIS;
OSTEOPOROSIS;
PRACTICE GUIDELINE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ALENDRONATE;
CALCITONIN;
CALCIUM;
ESTROGEN REPLACEMENT THERAPY;
ETIDRONIC ACID;
EVIDENCE-BASED MEDICINE;
HUMANS;
META-ANALYSIS;
OSTEOPOROSIS;
PRACTICE GUIDELINES;
RANDOMIZED CONTROLLED TRIALS;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
VITAMIN D;
VITAMIN K 2;
|
|
EID: 2442700573
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (17)
|
